Pharmacists in the UK have raised alarms over patients using AI-edited photographs to fraudulently access weight-loss treatments like Mounjaro and Wegovy. Patients are manipulating images to appear clinically eligible, prompting calls for tougher verification checks. The practice poses serious health risks, particularly for those with eating disorders.
Under NHS guidelines, adults qualify for treatment with a BMI of 35 and a weight-related health condition, while private providers prescribe to those with a BMI of 30, or 27 with a condition. Chemists warn the normalization of these injections is driving patients to drastic measures. Sehar Shahid of the National Pharmacy Association highlighted cases of patients hiding weights in pockets.
Despite guidelines introduced nearly two years ago requiring video consultations and medical record checks, verifying eligibility through photographs alone is increasingly difficult as AI tools become more sophisticated. A University College London study estimated 1.6 million UK adults used GLP-1 medications in a 12-month period to early 2025, mostly through private online pharmacies charging £300 monthly. Ahsan Bhatti of Quick Meds noted patients subtly exaggerating abdominal size or altering body contours.
Experts warn these drugs are powerful prescription medicines with significant side effects, not cosmetic quick fixes. The Royal College of Psychiatrists' eating disorder faculty expressed concern over misuse, noting workarounds like live photography are not universally implemented. The General Pharmaceutical Council regulator emphasized the need for evolving regulations to protect patient safety amid technological changes.
Source: Financial Times Companies · Summarized by HeadlinesBriefing